Silence Therapeutics (SLN) Change in Account Payables (2021 - 2022)
Historic Change in Account Payables for Silence Therapeutics (SLN) over the last 5 years, with Q3 2024 value amounting to -$862735.3.
- Silence Therapeutics' Change in Account Payables fell 82457.14% to -$862735.3 in Q3 2024 from the same period last year, while for Sep 2024 it was $3.2 million, marking a year-over-year increase of 18991.35%. This contributed to the annual value of $54610.7 for FY2023, which is 9695.05% down from last year.
- Silence Therapeutics' Change in Account Payables amounted to -$862735.3 in Q3 2024, which was down 82457.14% from $5.9 million recorded in Q2 2024.
- Over the past 5 years, Silence Therapeutics' Change in Account Payables peaked at $5.9 million during Q2 2024, and registered a low of -$4.2 million during Q1 2022.
- For the 5-year period, Silence Therapeutics' Change in Account Payables averaged around $688904.9, with its median value being $939551.9 (2023).
- Examining YoY changes over the last 5 years, Silence Therapeutics' Change in Account Payables showed a top increase of 48142.13% in 2024 and a maximum decrease of 82457.14% in 2024.
- Quarter analysis of 5 years shows Silence Therapeutics' Change in Account Payables stood at $2.9 million in 2020, then crashed by 37.27% to $1.8 million in 2021, then plummeted by 247.3% to -$2.7 million in 2022, then skyrocketed by 134.77% to $939551.9 in 2023, then plummeted by 191.82% to -$862735.3 in 2024.
- Its Change in Account Payables stands at -$862735.3 for Q3 2024, versus $5.9 million for Q2 2024 and -$2.7 million for Q1 2024.